When did BioPlus Acquisition IPO?

BioPlus Acquisition (BIOSU) raised $200 million in an IPO on Friday, December 3rd 2021. The company issued 20,000,000 shares at a price of $10.00 per share.

NASDAQ:BIOSU

BioPlus Acquisition (BIOSU) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free BIOSU Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.80
▼
$10.84
50-Day Range: $10.80
▼
$10.90
52-Week Range: $10.06
▼
$11.56

Volume: 700 shs
Average Volume: 3,141 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get BioPlus Acquisition alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About BioPlus Acquisition Stock (NASDAQ:BIOSU)

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

BIOSU Stock News Headlines

February 3, 2022 | nasdaq.com

BioPlus Acquisition Corp. Unit (BIOSU)

January 31, 2022 | finance.yahoo.com

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

See More Headlines

Receive BIOSU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Sub-Industry: N/A
Current Symbol: NASDAQ:BIOSU
CUSIP: N/A
CIK: 1856653
Web: bioplusspac.com
Phone: 212-287-4092
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Jonathan M. N. Rigby MBA (Age 55)
Chairman & Chief Bus. Officer
Mr. R. Ross Haghighat (Age 59)
CEO, CFO & Director

Key Competitors

View All Competitors

BIOSU Stock Analysis - Frequently Asked Questions

When did BioPlus Acquisition IPO?: BioPlus Acquisition (BIOSU) raised $200 million in an IPO on Friday, December 3rd 2021. The company issued 20,000,000 shares at a price of $10.00 per share.

This page (NASDAQ:BIOSU) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BioPlus Acquisition (BIOSU) Stock Price, News & Analysis

About BioPlus Acquisition Stock (NASDAQ:BIOSU)

BIOSU Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BIOSU Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info